Lab Reagents

Biotez Laboratories manufactures the biotez btafek-001 reagents distributed by Genprice. The Biotez Btafek-001 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact BioTez. Other Biotez products are available in stock. Specificity: Biotez Category: Btafek-001

Test Assays information

ICG-001
E1KS2662 5mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 521

ICG 001
A8217-10 10 mg
EUR 176
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

ICG 001
A8217-100 100 mg
EUR 724
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

ICG 001
A8217-25 25 mg
EUR 344
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

ICG 001
A8217-5 5 mg
EUR 126
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

ICG 001
A8217-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

ICG 001
A8217-S Evaluation Sample
EUR 81
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

TOK-001
A8623-10 10 mg
EUR 235
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

TOK-001
A8623-5.1 10 mM (in 1mL DMSO)
EUR 166
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

TOK-001
A8623-50 50 mg
EUR 595
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

ICG-001
HY-14428 100mg
EUR 807

RRx-001
HY-16438 100mg
EUR 1840

RP 001 hydrochloride
B7634-10 10 mg
EUR 332

RP 001 hydrochloride
B7634-25 25 mg
EUR 656

RP 001 hydrochloride
B7634-5 5 mg
EUR 232

ICG-001 ( ?-catenin inhibitor)
SIH-387-25MG 25 mg
EUR 577
  • Inhibitor of TCF/?-catenin-mediated transcription. Selectively inhibits ?-catenin/CBP interaction
  • displays no effect on ?-catenin/p300 interaction. Exhibits growth inhibitory effects in colon carcinoma cell lines (SW480 and HCT-116 cells)
  • also disp
  • Show more
Description: The substance ICG-001 is a ?-catenin inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 50 mM in ethanol.

ICG-001 ( ?-catenin inhibitor)
SIH-387-5MG 5 mg
EUR 209
  • Inhibitor of TCF/?-catenin-mediated transcription. Selectively inhibits ?-catenin/CBP interaction
  • displays no effect on ?-catenin/p300 interaction. Exhibits growth inhibitory effects in colon carcinoma cell lines (SW480 and HCT-116 cells)
  • also disp
  • Show more
Description: The substance ICG-001 is a ?-catenin inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 50 mM in ethanol.